NCT02117518View on ClinicalTrials.gov

Selective Immunotargeting of Pathogenic CD8 T Cells of Type 1 Diabetes Patients

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions
Type I Diabetes
Interventions
OTHER

blood drawing

Trial Locations (1)

13100

Ziv Medical Center, Safed

Sponsors
All Listed Sponsors
collaborator

Ziv Medical Center

OTHER

lead

Migal Galilee Research Institute

OTHER